An observational cohort study on terminal cancer survivors practicing falun gong (FLG) in China.
Publication: Journal of Clinical Oncology
Abstract
e21568
Background: In China, cancer patients may choose to practice FLG -- the most popular Qigong since 1992 -- after treatment failure, arousing great interest in the medical society. Methods: We collected reports from Chinese cancer patients between 2000 and 2015 via a web platform, including diagnosis, FLG practice duration, Actual Survival (AS) till report date, symptom improvement, and Quality of Life (QoL). All reports were reviewed by 2 physicians. Predicted Survival (PS) was assessed using the NIH SEER data if the treating physician’s Clinical Prediction of Survival (CPS) was unavailable. Reports of terminal cancer patients (PS ≤ 12 months) with sufficient and verifiable medical information were considered eligible. Symptom Free Survival (SFS) was also calculated. Results: In the web database, using the search terms "late-stage" and “cancer", we found 406 prospective cases, wherein 152 terminal cases (PS ≤ 12 months) were deemed eligible. Primary cancer types included lung (n = 38), liver (n = 29), stomach (n = 17), leukemia (n = 12), esophagus (n = 10), gynecological (n = 9), pancreas/bile duct (n = 8), colorectal (n = 7), and others (n = 22). The onset age was 53.3±15.6 years. Among them, 65 patients experienced cancer treatment failure, 74 patients did not take any further cancer treatment after diagnosis, and 13 patients received treatment along with FLG practice. The FLG practice duration was 53.1±58.9 months. As of the report date, 149 patients were still alive. Compared with PS (5.1±2.7 months), AS was significantly prolonged to 56.0±60.1 months (P < 0.0001). CPS (5.1±2.0 months) was close to SEER survival (5.2±3.2 months), indicating the reliability of CPS and these reports. Time to Effect was 1.3±1.7 months. A total of 147 patients (96.7%) reported complete symptom recovery with 60 patients confirmed by treating physicians. Time to Symptom Recovery was 3.6±3.3 months, and SFS was 52.7±61.1 months. QoL after FLG practice significantly improved (all Ps < 0.0001). Multivariate analysis showed FLG practice duration was the dominating predictive factor for AS and SFS. Conclusions: We observed that FLG practice can help terminal cancer patients survive significantly longer, in addition to notable symptom improvement.
Information & Authors
Information
Published In
Copyright
© 2016 by American Society of Clinical Oncology.
History
Published online: May 20, 2016
Published in print: May 20, 2016
Authors
Metrics & Citations
Metrics
Altmetric
Citations
Article Citation
An observational cohort study on terminal cancer survivors practicing falun gong (FLG) in China.. JCO 34, e21568-e21568(2016).
Download Citation
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Download article citation data for:
Journal of Clinical Oncology 2016 34:15_suppl, e21568-e21568
Journal of Clinical Oncology 2016 34:15_suppl, e21568-e21568
View Options
View options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.
Subscribe
Subscribe to this Journal
Renew Your Subscription
Become a Member